JKT · SRAJ.JK
PT Sejahteraraya Anugrahjaya Tbk
IDR 10,850-IDR 125 (-1.14%)
PT Sejahteraraya Anugrahjaya Tbk’s quoted price sits in the lower half of its reported 52-week range, 43.49% below the high.
Loading market information…
JKT · SDPC.JK · IDR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 08:28 AM UTC. Cached market data; not a live quote.
One-year closing-price history · IDR. Historical prices are not a forecast.
PT Millennium Pharmacon International Tbk’s quoted price sits in the upper half of its reported 52-week range, 13.16% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
PT Millennium Pharmacon International Tbk’s forward annual dividend is IDR 3 per share, paid annual. The forward yield is 1.52% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow PT Millennium Pharmacon International Tbk’s reporting calendar.
THE COMPANY BEHIND THE TICKER
PT Millennium Pharmacon International Tbk is an Indonesian enterprise specializing in the wholesale and provision of a diverse range of healthcare products. This includes both prescription and over-the-counter medicines, nutritional supplements, and medical equipment. The company's comprehensive distribution channels extend to various points of sale, such as retail pharmacies, hospitals, supermarkets, and other retail establishments. As of December 31, 2021, it managed 33 regional offices strategically located across Indonesia's major islands, including Java, Bali, Sumatera, Kalimantan, and Sulawesi. Founded in 1952, the organization was originally known as PT NVPD Soedarpo Corporation Tbk before adopting its current designation, PT Millennium Pharmacon International Tbk, in February 1990. Its corporate headquarters are situated in Jakarta Selatan, Indonesia, and it operates as a subsidiary of Pharmaniaga International Corporation Sdn. Bhd.
Latest available per-share figures in IDR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
IDR 10,850-IDR 125 (-1.14%)
PT Sejahteraraya Anugrahjaya Tbk’s quoted price sits in the lower half of its reported 52-week range, 43.49% below the high.
IDR 730+IDR 15 (+2.1%)
PT Kalbe Farma Tbk.’s quoted price sits in the lower half of its reported 52-week range, 45.52% below the high.
IDR 350-IDR 4 (-1.13%)
PT Itama Ranoraya Tbk’s quoted price sits in the lower half of its reported 52-week range, 43.09% below the high.
IDR 123+IDR 1 (+0.82%)
PT Royal Prima Tbk’s quoted price sits in the upper half of its reported 52-week range, 8.21% below the high.
IDR 278-IDR 2 (-0.71%)
PT Diagnos Laboratorium Utama Tbk’s quoted price sits in the upper half of its reported 52-week range, 27.23% below the high.
IDR 254IDR 0 (0.0%)
PT Phapros, Tbk’s quoted price sits in the lower half of its reported 52-week range, 44.78% below the high.
IDR 24-IDR 2 (-7.69%)
PT Nanotech Indonesia Global Tbk’s quoted price sits in the lower half of its reported 52-week range, 64.18% below the high.
IDR 58-IDR 3 (-4.92%)
PT Hetzer Medical Indonesia Tbk’s quoted price sits in the lower half of its reported 52-week range, 63.06% below the high.
